Literature DB >> 23410246

Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy.

S Hauerslev1, M C Ørngreen, J M Hertz, J Vissing, T O Krag.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to investigate whether inflammation and regeneration are prominent in mildly affected muscles of patients with facioscapulohumeral muscular dystrophy type 1A (FSHD1A). Inflammation in muscle has been suggested by MRI studies in patients with FSHD1A.
METHODS: We analysed immunohistological and histological stains of muscle biopsies from 24 patients with FSHD1A, using 10 patients with Becker muscular dystrophy (BMD) for comparison.
RESULTS: Internalized nuclei were more prevalent in BMD (23.7 ± 10.8%) vs FSHD1A (6.3 ± 6.8%; P < 0.001), indicating more past regenerating fibres in BMD. Recently regenerating fibres, expressing neonatal myosin heavy chain and vimentin, did not differ significantly between patients with FSHD1A (1.1 ± 2.9%) and patients with BMD (1.8 ± 1.9%). Regeneration was not correlated with the number of KpnI restriction fragment repeats, an FSHD1A-defining genotype property within the D4Z4 locus, or overall disease severity in patients with FSHD1A. Macrophages were more prevalent in FSHD1A (0.50 ± 0.63 per mm(2) ) vs BMD (0.07 ± 0.07 per mm(2) ), whereas inflammatory T cells were equally infrequent.
CONCLUSIONS: Macrophages were more prevalent in patients with FSHD1A and could be an important pathogenic mechanism for the initiation of the dystrophic process. Furthermore, regeneration was unrelated to genotype and disease severity in FSHD1A.
© 2013 John Wiley & Sons A/S.

Entities:  

Keywords:  FSHD1A; inflammation; internally nucleated fibres; muscle regeneration; neonatal myosin heavy chain

Mesh:

Substances:

Year:  2013        PMID: 23410246     DOI: 10.1111/ane.12109

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

Review 1.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

2.  Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Authors:  Giorgio Tasca; Mauro Monforte; Maddalena Corbi; Giuseppe Granata; Donatella Lucchetti; Alessandro Sgambato; Enzo Ricci
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

Review 3.  Skeletal muscle regeneration is modulated by inflammation.

Authors:  Wenjun Yang; Ping Hu
Journal:  J Orthop Translat       Date:  2018-02-07       Impact factor: 5.191

Review 4.  Cellular and animal models for facioscapulohumeral muscular dystrophy.

Authors:  Alec M DeSimone; Justin Cohen; Monkol Lek; Angela Lek
Journal:  Dis Model Mech       Date:  2020-10-28       Impact factor: 5.758

5.  Downstream events initiated by expression of FSHD-associated DUX4: Studies of nucleocytoplasmic transport, γH2AX accumulation, and Bax/Bak-dependence.

Authors:  Isabel F Masteika; Anvitha Sathya; Sachiko Homma; Bess M Miller; Frederick M Boyce; Jeffrey Boone Miller
Journal:  Biol Open       Date:  2022-02-22       Impact factor: 2.422

Review 6.  Stem cell transplantation for muscular dystrophy: the challenge of immune response.

Authors:  Sara Martina Maffioletti; Maddalena Noviello; Karen English; Francesco Saverio Tedesco
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

7.  Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.

Authors:  E Reimann; K Kingo; M Karelson; P Reemann; E Vasar; H Silm; S Kõks
Journal:  Dermatopathology (Basel)       Date:  2014-01-09

Review 8.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

9.  Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy.

Authors:  Hui-Ting Lin; Xiao Liu; Wei Zhang; Jing Liu; Yue-Huan Zuo; Jiang-Xi Xiao; Ying Zhu; Yun Yuan; Zhao-Xia Wang
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.